| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 176.7K | $12.84M | - | |
| CEO | 80.5K | $5.85M | - | |
| Dir | 80.0K | $5.81M | - | |
| Dir | 59.6K | $4.33M | - | |
| Pres | 25.0K | $1.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2019 | John L Higgins66 | Director | Sale+OE | 5,000 | $203.67 | $1,018,345.50 | -58.6% | |
| May 24, 2019 | Brenda S. Furlow70 | SVP - General Counsel | Sale+OE | 5,400 | $200.00 | $1,080,000.00 | -71.2% | |
| May 1, 2019 | James Hippel74 | Chief Financial Officer | Sale+OE | 35,000 | $203.08 | $7,107,681.00 | -88.9% | |
| Aug 24, 2018 | Robert V Baumgartner45 | Director | Sale+OE | 5,000 | $188.47 | $942,333.50 | -39.3% | |
| Aug 23, 2018 | John L Higgins66 | Director | Sale+OE | 10,000 | $187.92 | $1,879,173.00 | -76.9% | |
| Aug 8, 2018 | Charles A Dinarello | Director | Sale+OE | 5,000 | $176.94 | $884,675.00 | -37.8% | |
| Jun 7, 2018 | Charles R. Kummeth77 | Chief Executive Officer | Sell | 8,000 | $160.00 | $1,280,000.00 | -9.5% | |
| May 4, 2018 | Norman David Eansor52 | SVP - Novus Biologicals | Sell | 1,136 | $145.19 | $164,931.75 | -33.4% | |
| Feb 13, 2018 | Charles A Dinarello | Director | Sale+OE | 5,000 | $136.06 | $680,303.00 | -37.8% | |
| Nov 1, 2017 | Robert V Baumgartner45 | Director | Sale+OE | 5,000 | $130.18 | $650,907.00 | -39.3% |